Själander A - Search Results

1

Reduced dose direct oral anticoagulants compared with warfarin with high time in therapeutic range in nonvalvular atrial fibrillation.

Jansson M, Själander S, Sjögren V, Björck F, Renlund H, Norrving B, Själander A. Jansson M, et al. Among authors: sjalander s, sjalander a. J Thromb Thrombolysis. 2023 Apr;55(3):415-425. doi: 10.1007/s11239-022-02763-w. Epub 2023 Jan 6. J Thromb Thrombolysis. 2023. PMID: 36607464 Free PMC article.

2

[Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].

Själander A, Wallentin L, Rosenqvist M, Svensson P. Själander A, et al. Lakartidningen. 2008 Sep 10-16;105(37):2478-80. Lakartidningen. 2008. PMID: 19006862 Swedish. No abstract available.

3

Cardiovascular Events Associated With Use of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Population-Based Cohort Study.

Dahlén T, Edgren G, Lambe M, Höglund M, Björkholm M, Sandin F, Själander A, Richter J, Olsson-Strömberg U, Ohm L, Bäck M, Stenke L; Swedish CML Group and the Swedish CML Register Group. Dahlén T, et al. Among authors: sjalander a. Ann Intern Med. 2016 Aug 2;165(3):161-6. doi: 10.7326/M15-2306. Epub 2016 Jun 14. Ann Intern Med. 2016. PMID: 27295519

4

[Guidelines for anticoagulation in patients with valve prosthesis. More supposition than scientific evidence].

Själander A, Jeppsson A, Svensson PJ. Själander A, et al. Lakartidningen. 2010 Sep 29-Oct 5;107(39):2326-8. Lakartidningen. 2010. PMID: 20973249 Review. Swedish. No abstract available.

5

[Investigation of thrombosis--only when the patient benefits from the results].

Själander A, Missios A, Mulugeta E, Wetterlöv T, Svensson PJ. Själander A, et al. Lakartidningen. 2010 Mar 10-16;107(10):679-81. Lakartidningen. 2010. PMID: 20402252 Review. Swedish. No abstract available.

6

[Evidence for thrombosis prophylaxis to high-risk patients].

Själander A, Jansson JH, Bergqvist D, Eriksson H, Svensson P. Själander A, et al. Lakartidningen. 2007 May 14-29;104(20-21):1585-7. Lakartidningen. 2007. PMID: 17564265 Review. Swedish. No abstract available.

7

Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia.

Saglio G, Kim DW, Issaragrisil S, le Coutre P, Etienne G, Lobo C, Pasquini R, Clark RE, Hochhaus A, Hughes TP, Gallagher N, Hoenekopp A, Dong M, Haque A, Larson RA, Kantarjian HM; ENESTnd Investigators. Saglio G, et al. N Engl J Med. 2010 Jun 17;362(24):2251-9. doi: 10.1056/NEJMoa0912614. Epub 2010 Jun 5. N Engl J Med. 2010. PMID: 20525993 Free article. Clinical Trial.

8

[Prothrombin complex concentrate good in warfarin induced hemorrhage. Quick reversal--plasma should be avoided].

Själander A, Berntorp E, Svensson PJ. Själander A, et al. Lakartidningen. 2009 Sep 9-15;106(37):2278, 2280-1. Lakartidningen. 2009. PMID: 19817161 Swedish. No abstract available.

9

[Thrombocytopenia can be HIT. Heparin treatment can cause low life-threatening thrombocyte levels].

Själander A, Johansson L, Hillarp A, Bergqvist D, Tengborn L, Svensson P. Själander A, et al. Lakartidningen. 2009 Mar 4-10;106(10):682-5. Lakartidningen. 2009. PMID: 19418688 Swedish. No abstract available.

10

[Auricular already exists!].

Själander A. Själander A. Lakartidningen. 2008 May 21-27;105(21):1594; author reply 1594. Lakartidningen. 2008. PMID: 18575001 Swedish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

96 results

Search Page